메뉴 건너뛰기




Volumn 21, Issue 6, 2010, Pages 545-547

Nutrition and metabolism: Nutritional therapy for disordered triglyceride metabolism and nonalcoholic fatty liver disease

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ATORVASTATIN; DOCOSAHEXAENOIC ACID; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PHYTOSTEROL; PIOGLITAZONE; STANOL ESTER; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

EID: 78649343879     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283404fb5     Document Type: Note
Times cited : (8)

References (17)
  • 1
    • 77951875017 scopus 로고    scopus 로고
    • Triglyceride-mediated pathways and coronary disease: Collaborative analysis of 101 studies
    • Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration
    • Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010; 375:1634-1639.
    • (2010) Lancet , vol.375 , pp. 1634-1639
    • Sarwar, N.1    Sandhu, M.S.2    Ricketts, S.L.3
  • 2
    • 33645978418 scopus 로고    scopus 로고
    • Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease
    • Goldberg IJ, Ginsberg HN. Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Gastroenterology 2006; 130:1343-1346.
    • (2006) Gastroenterology , vol.130 , pp. 1343-1346
    • Goldberg, I.J.1    Ginsberg, H.N.2
  • 3
    • 33947108446 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and increased risk of cardiovascular disease
    • Targher G, Arcaro G. Nonalcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191:235-240.
    • (2007) Atherosclerosis , vol.191 , pp. 235-240
    • Targher, G.1    Arcaro, G.2
  • 4
    • 77950499307 scopus 로고    scopus 로고
    • Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity
    • Chan DC, Nguyen MN, Watts GF, et al. Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity. Am J Clin Nutr 2010; 91:900-906.
    • (2010) Am J Clin Nutr , vol.91 , pp. 900-906
    • Chan, D.C.1    Nguyen, M.N.2    Watts, G.F.3
  • 5
    • 67349267865 scopus 로고    scopus 로고
    • Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria
    • Bell S, Cooney J, Packard CJ, et al. Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria. Atherosclerosis 2009; 205:296-301.
    • (2009) Atherosclerosis , vol.205 , pp. 296-301
    • Bell, S.1    Cooney, J.2    Packard, C.J.3
  • 6
    • 70349902776 scopus 로고    scopus 로고
    • Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: A randomized controlled trial employing proton magnetic resonance spectroscopy
    • Cussons AJ, Watts GF, Mori TA, Stuckey BG. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab 2009; 94:3842-3848.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 3842-3848
    • Cussons, A.J.1    Watts, G.F.2    Mori, T.A.3    Stuckey, B.G.4
  • 7
    • 77649216380 scopus 로고    scopus 로고
    • Review article: Omega-3 fatty acids - A promising novel therapy for nonalcoholic fatty liver disease
    • Masterton GS, Plevris JN, Hayes PC. Review article: omega-3 fatty acids - a promising novel therapy for nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2010; 31:679-692.
    • (2010) Aliment Pharmacol Ther , vol.31 , pp. 679-692
    • Masterton, G.S.1    Plevris, J.N.2    Hayes, P.C.3
  • 8
    • 0042206849 scopus 로고    scopus 로고
    • Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels
    • Stresa Workshop Participants
    • Katan MB, Grundy SM, Jones P, et al., Stresa Workshop Participants. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003; 78:965-978.
    • (2003) Mayo Clin Proc , vol.78 , pp. 965-978
    • Katan, M.B.1    Grundy, S.M.2    Jones, P.3
  • 9
    • 42649086181 scopus 로고    scopus 로고
    • The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations
    • Naumann E, Plat J, Kester AD, Mensink RP. The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J Am Coll Nutr 2008; 27:117-126.
    • (2008) J Am Coll Nutr , vol.27 , pp. 117-126
    • Naumann, E.1    Plat, J.2    Kester, A.D.3    Mensink, R.P.4
  • 10
    • 66749118878 scopus 로고    scopus 로고
    • A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients
    • Plat J, Brufau G, Dallinga-Thie GM, et al. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J Nutr 2009; 139:1143-1149.
    • (2009) J Nutr , vol.139 , pp. 1143-1149
    • Plat, J.1    Brufau, G.2    Dallinga-Thie, G.M.3
  • 11
    • 71149093699 scopus 로고    scopus 로고
    • Plant stanol esters lower serum triacylglycerol concentrations via a reduced hepatic VLDL-1 production
    • Plat J, Mensink RP. Plant stanol esters lower serum triacylglycerol concentrations via a reduced hepatic VLDL-1 production. Lipids 2009; 44:1149-1153.
    • (2009) Lipids , vol.44 , pp. 1149-1153
    • Plat, J.1    Mensink, R.P.2
  • 12
    • 77952674608 scopus 로고    scopus 로고
    • Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet
    • Chan DC, Watts GF, Gan SK, et al. Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. Diabetes Care 2010; 33:1134-1139.
    • (2010) Diabetes Care , vol.33 , pp. 1134-1139
    • Chan, D.C.1    Watts, G.F.2    Gan, S.K.3
  • 13
    • 33845511343 scopus 로고    scopus 로고
    • Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols
    • Demonty I, Chan YM, Pelled D, Jones PJ. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am J Clin Nutr 2006; 84:1534-1542.
    • (2006) Am J Clin Nutr , vol.84 , pp. 1534-1542
    • Demonty, I.1    Chan, Y.M.2    Pelled, D.3    Jones, P.J.4
  • 14
    • 77951632835 scopus 로고    scopus 로고
    • Prevention and treatment of nonalcoholic fatty liver disease
    • Targher G, Bellis A, Fornengo P, et al. Prevention and treatment of nonalcoholic fatty liver disease. Dig Liver Dis 2010; 42:331-340.
    • (2010) Dig Liver Dis , vol.42 , pp. 331-340
    • Targher, G.1    Bellis, A.2    Fornengo, P.3
  • 15
    • 77951874018 scopus 로고    scopus 로고
    • NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
    • Sanyal AJ, Chalasani N, Kowdley KV, et al., NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362:1675-1685.
    • (2010) N Engl J Med , vol.362 , pp. 1675-1685
    • Sanyal, A.J.1    Chalasani, N.2    Kowdley, K.V.3
  • 16
    • 77950202777 scopus 로고    scopus 로고
    • Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
    • Petersen KF, Dufour S, Hariri A, et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010; 362:1142-1143.
    • (2010) N Engl J Med , vol.362 , pp. 1142-1143
    • Petersen, K.F.1    Dufour, S.2    Hariri, A.3
  • 17
    • 56749096610 scopus 로고    scopus 로고
    • Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
    • Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40:1461-1465.
    • (2008) Nat Genet , vol.40 , pp. 1461-1465
    • Romeo, S.1    Kozlitina, J.2    Xing, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.